Previous Next
In rheumatoid arthritis, the identification of blood biomarkers of endothelial dysfunction, a precursor of atherosclerosis, would enable us to better assess risk and define appropriate prevention strategies. While ischemia-modified albumin is already used in the assessment of oxidative stress, ischemia and erectile dysfunction, this biomarker had not previously been evaluated in erectile dysfunction in rheumatoid arthritis patients. This study, conducted on 113 patients with no prior cardiovascular history, demonstrated a significant inverse association between peripheral vasodilator capacity and ischemia-modified albumin levels. The association between erectile dysfunction and ischemia-modified albumin remained significant after adjustment for factors influencing rheumatoid arthritis.

Source(s) :
Gian Luca Erre et al. Association between ischemia-modified albumin (IMA) and peripheral endothelial dysfunction in rheumatoid arthritis patients. Sci Rep. 2024 Feb 17;14(1):3964. ;

Last press reviews


Functional Brain Dysconnectivity: A key to understanding mood and psychotic disorders?

Mood and psychotic disorders affect millions of people worldwide, profound...

Blood biomarkers for tuberculosis diagnosis in HIV patients

Tuberculosis (TB) is a major cause of morbidity and mortality among people...

HIV and Dual Therapy: a promising step towards maintaining viral suppression

The introduction of dual therapies in HIV treatment marks a significant ad...